About the Authors

Klaus Reither

Klaus.Reither@unibas.ch

Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University Basel, Basel, Switzerland, Ifakara Health Institute, Bagamoyo, Tanzania

Lynn Katsoulis

Affiliation Aurum Institute, Johannesburg, South Africa

Trevor Beattie

Affiliation Aurum Institute, Johannesburg, South Africa

Nicolene Gardiner

Affiliation Aurum Institute, Johannesburg, South Africa

Nicole Lenz

Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University Basel, Basel, Switzerland

Khadija Said

Affiliation Ifakara Health Institute, Bagamoyo, Tanzania

Elirehema Mfinanga

Affiliation Ifakara Health Institute, Bagamoyo, Tanzania

Christian Pohl

Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University Basel, Basel, Switzerland, Ifakara Health Institute, Bagamoyo, Tanzania

Katherine L. Fielding

Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

Hannah Jeffery

Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom

Benjamin M. Kagina

Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

Elisabeth J. Hughes

Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

Thomas J. Scriba

Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

Willem A. Hanekom

Affiliation South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa

Søren T. Hoff

Affiliation Statens Serum Institute, Department of Infectious Disease Immunology, Copenhagen, Denmark

Peter Bang

Affiliation Statens Serum Institute, Department of Vaccine Development, Copenhagen, Denmark

Ingrid Kromann

Affiliation Statens Serum Institute, Department of Vaccine Development, Copenhagen, Denmark

Claudia Daubenberger

Affiliations Swiss Tropical and Public Health Institute, Basel, Switzerland, University Basel, Basel, Switzerland

Peter Andersen

Affiliation Statens Serum Institute, Department of Infectious Disease Immunology, Copenhagen, Denmark

Gavin J. Churchyard

Affiliations Aurum Institute, Johannesburg, South Africa, London School of Hygiene and Tropical Medicine, London, United Kingdom, School of Public Health, University of Witwatersrand, Johannesburg, South Africa

Competing Interests

Ingrid Kromann, Peter Bang, and Søren T. Hoff are employed by the Statens Serum Institut, a Danish not-for-profit governmental research institution which holds intellectual property rights on H1 as a vaccine construct. Peter Andersen is a co-inventor on a patent application covering the use of H1 as a vaccine (Patent No. WO9844119; Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis). All rights have been assigned to Statens Serum Institut. The patent does not alter the authors’ adherence to PLOS ONE policies on sharing data. The other authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: GJC LK TB KR STH PB IK PA CD. Performed the experiments: GJC KR LK TB NG KS EM CP NL BMK EJH TJS WAH STH CD PA. Analyzed the data: KLF HJ. Wrote the paper: KR GJC LK TB KLF TJS BMK STH PB IK CD PA. Contributed to data collection, interpretation of data, and revision and approval of the article: GJC KR LK TB NG KS EM CP NL BMK EJH TJS WAH STH CD PA KLF HJ PB IK.